Unlike other AI-produced drugs in trials, INS018_055 is the first drug with both a novel AI-discovered target and a novel AI-generated designHong Kong-based biotech InSilico Medicine has used artificial intelligence (AI) to create the drug INS018-055 to help treat idiopathic pulmonary fibrosis (IPF).IPF is a disease whereby the tissue surrounding the alveoli in the lungs […]
